×
Assembly Biosciences Share Holder Equity 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Assembly Biosciences share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
View More
Assembly Biosciences Share Holder Equity 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Assembly Biosciences share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$24.9B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$6.8B
Bausch Health Cos (BHC)
$2.8B
Supernus Pharmaceuticals (SUPN)
$2.1B
Amphastar Pharmaceuticals (AMPH)
$1.7B
Personalis (PSNL)
$396M
Taysha Gene Therapies (TSHA)
$314M
Sol-Gel Technologies (SLGL)
$25M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M